Medscape highlighted research presented by Krunal H. Patel, MD, Pulmonary and Critical Care Fellow at the Temple Lung Center, at the CHEST Annual Meeting in Chicago on the findings from the PEERLESS trial, which showed that large-bore mechanical thrombectomy (LBMT) was superior to catheter-directed thrombolysis (CDT) for treatment of intermediate-risk pulmonary embolism (PE).